Coherus BioSciences, Inc. (CHRS)
USD 1.1
(4.76%)
USD 1.1
(4.76%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 480.84 Million USD | 2.08% |
| 2022 | 471.05 Million USD | 15.38% |
| 2021 | 408.28 Million USD | 1.05% |
| 2020 | 404.02 Million USD | 126.49% |
| 2019 | 178.38 Million USD | 73.04% |
| 2018 | 103.09 Million USD | 1.66% |
| 2017 | 101.41 Million USD | 1.15% |
| 2016 | 100.25 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 4.2 Million USD | 141.83% |
| 2012 | 1.73 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 481.16 Million USD | 0.07% |
| 2024 Q2 | 298.34 Million USD | -38.0% |
| 2023 Q4 | 480.84 Million USD | 0.45% |
| 2023 Q2 | 479.25 Million USD | 1.62% |
| 2023 Q1 | 471.61 Million USD | 0.12% |
| 2023 Q3 | 478.67 Million USD | -0.12% |
| 2023 FY | 480.84 Million USD | 2.08% |
| 2022 Q3 | 480.71 Million USD | 11.34% |
| 2022 Q4 | 471.05 Million USD | -2.01% |
| 2022 FY | 471.05 Million USD | 15.38% |
| 2022 Q1 | 430.34 Million USD | 5.4% |
| 2022 Q2 | 431.76 Million USD | 0.33% |
| 2021 Q2 | 417.94 Million USD | 0.09% |
| 2021 Q4 | 408.28 Million USD | -2.5% |
| 2021 FY | 408.28 Million USD | 1.05% |
| 2021 Q3 | 418.77 Million USD | 0.2% |
| 2021 Q1 | 417.55 Million USD | 3.35% |
| 2020 Q1 | 190.15 Million USD | 6.6% |
| 2020 FY | 404.02 Million USD | 126.49% |
| 2020 Q4 | 404.02 Million USD | -2.35% |
| 2020 Q3 | 413.76 Million USD | 2.91% |
| 2020 Q2 | 402.06 Million USD | 111.45% |
| 2019 FY | 178.38 Million USD | 73.04% |
| 2019 Q1 | 183.15 Million USD | 77.67% |
| 2019 Q2 | 177.17 Million USD | -3.27% |
| 2019 Q3 | 177.77 Million USD | 0.34% |
| 2019 Q4 | 178.38 Million USD | 0.34% |
| 2018 Q4 | 103.09 Million USD | 0.37% |
| 2018 FY | 103.09 Million USD | 1.66% |
| 2018 Q3 | 102.7 Million USD | 0.37% |
| 2018 Q2 | 102.33 Million USD | 0.36% |
| 2018 Q1 | 101.96 Million USD | 0.55% |
| 2017 Q3 | 101.25 Million USD | 0.34% |
| 2017 Q2 | 100.91 Million USD | 0.33% |
| 2017 Q1 | 100.58 Million USD | 0.33% |
| 2017 FY | 101.41 Million USD | 1.15% |
| 2017 Q4 | 101.41 Million USD | 0.15% |
| 2016 FY | 100.25 Million USD | 0.0% |
| 2016 Q2 | 99.62 Million USD | 0.31% |
| 2016 Q4 | 100.25 Million USD | 0.32% |
| 2016 Q1 | 99.32 Million USD | 0.0% |
| 2016 Q3 | 99.93 Million USD | 0.31% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q4 | - USD | -100.0% |
| 2014 Q2 | 1.58 Million USD | -76.3% |
| 2014 Q1 | 6.7 Million USD | 59.55% |
| 2014 FY | - USD | -100.0% |
| 2014 Q3 | 2.29 Million USD | 44.49% |
| 2013 Q4 | 4.2 Million USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 4.2 Million USD | 141.83% |
| 2012 FY | 1.73 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -338521.127% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -6179.445% |
| XOMA Corporation | 124.45 Million USD | -286.374% |
| Mesoblast Limited | 118.92 Million USD | -304.331% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -109.8% |
| Aptorum Group Limited | 3.36 Million USD | -14200.572% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -36910.166% |
| HilleVax, Inc. | 51.19 Million USD | -839.273% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1820.142% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -2202.416% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1437.809% |
| Dyadic International, Inc. | 136.92 Thousand USD | -351061.551% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -304230.38% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -16642.409% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -8714.702% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -224592.523% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -8692.138% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -109.579% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -3770.267% |
| IGM Biosciences, Inc. | 40.5 Million USD | -1087.088% |
| Opthea Limited | 200.62 Million USD | -139.667% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -828.715% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -8804.481% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -4800.051% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -7699.546% |
| NextCure, Inc. | 6.6 Million USD | -7179.97% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -77205.415% |
| Ovid Therapeutics Inc. | 46 Million USD | -945.269% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -2163.958% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1491.349% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -674.615% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1176.594% |
| Apollomics, Inc. | 4.66 Million USD | -10216.284% |
| PureTech Health plc | 25.51 Million USD | -1784.768% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -151108.176% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -3605.626% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -467.874% |
| ChromaDex Corporation | 3.27 Million USD | -14573.238% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -361.54% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1161.92% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -358.928% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -364.42% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -374.278% |
| Fortress Biotech, Inc. | 88.59 Million USD | -442.76% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -661.223% |
| Celcuity Inc. | 37.44 Million USD | -1184.085% |
| ContextLogic Inc. | 6 Million USD | -7914.033% |
| GH Research PLC | 343 Thousand USD | -140087.172% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -7231.026% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1299472.973% |
| ImmuCell Corporation | 11.96 Million USD | -3917.293% |
| Amarin Corporation plc | 8.73 Million USD | -5403.514% |
| TG Therapeutics, Inc. | 110.79 Million USD | -333.993% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -725.041% |
| Acelyrin, Inc. | 1.19 Million USD | -40171.524% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -1601.553% |
| Novavax, Inc. | 280.63 Million USD | -71.341% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -245.855% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 91.705% |
| AnaptysBio, Inc. | 17.81 Million USD | -2599.237% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -8809.431% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -3519.163% |
| AbCellera Biologics Inc. | 77.38 Million USD | -521.403% |
| CorMedix Inc. | 667.63 Thousand USD | -71922.012% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -4289.247% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 82.21% |
| Aptose Biosciences Inc. | 1 Million USD | -47517.265% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -5554913.863% |
| Soligenix, Inc. | 3.49 Million USD | -13659.725% |
| Century Therapeutics, Inc. | 48.17 Million USD | -898.198% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -317.503% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -106618.364% |
| Kura Oncology, Inc. | 17.2 Million USD | -2695.593% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -6862.67% |
| Ardelyx, Inc. | 55.98 Million USD | -758.923% |
| Ainos, Inc. | 5.96 Million USD | -7963.008% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -420.206% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -22264.744% |
| Prothena Corporation plc | 11.83 Million USD | -3962.881% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -3340.976% |
| Autolus Therapeutics plc | 52.96 Million USD | -807.814% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1805.457% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -1049.158% |
| Celularity Inc. | 65.41 Million USD | -635.041% |
| Rallybio Corporation | 392 Thousand USD | -122563.776% |
| GRI Bio, Inc. | 14 Thousand USD | -3434485.714% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | -42.143% |
| INmune Bio, Inc. | 10.43 Million USD | -4507.09% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -167.688% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -8040.125% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -588590.01% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -58053.896% |
| Humacyte, Inc. | 58.1 Million USD | -727.526% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -730.872% |
| Immunocore Holdings plc | 84.03 Million USD | -472.213% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -25849.379% |
| Verastem, Inc. | 41.55 Million USD | -1057.066% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -4128.298% |
| Histogen Inc. | 4.62 Million USD | -10303.332% |
| Surrozen, Inc. | 3.37 Million USD | -14130.305% |
| Blueprint Medicines Corporation | 774.12 Million USD | 37.886% |
| Organovo Holdings, Inc. | 1.39 Million USD | -34393.687% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -19179.952% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -828937.931% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -468.452% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -229945.929% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -9482.344% |
| Summit Therapeutics Inc. | 106.09 Million USD | -353.201% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -335.711% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -296136.377% |
| Turnstone Biologics Corp. | 3.21 Million USD | -14860.859% |
| Pulmatrix, Inc. | 8.75 Million USD | -5391.571% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -194572.874% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -392.631% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -3371.783% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -316.869% |
| Cytokinetics, Incorporated | 755.77 Million USD | 36.377% |
| Exelixis, Inc. | 189.94 Million USD | -153.149% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1470.66% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -333.472% |
| Evogene Ltd. | 1.13 Million USD | -42153.251% |
| Replimune Group, Inc. | 75.86 Million USD | -533.779% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1915.972% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -871543.252% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -17159.225% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -598498.247% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -983820.606% |
| BioLineRx Ltd. | 11.59 Million USD | -4048.408% |
| Avid Bioservices, Inc. | 207.83 Million USD | -131.359% |
| Insmed Incorporated | 1.2 Billion USD | 60.063% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -22581.226% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -950.493% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -739656.923% |
| MediWound Ltd. | 6.71 Million USD | -7064.983% |
| MiMedx Group, Inc. | 48.09 Million USD | -899.692% |
| OmniAb, Inc. | 25.56 Million USD | -1781.155% |
| Alector, Inc. | 38.91 Million USD | -1135.526% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -124.76% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -15.858% |
| Mereo BioPharma Group plc | 5.95 Million USD | -7978.663% |
| Zai Lab Limited | 15.15 Million USD | -3073.665% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -0.503% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -29309.297% |
| Aura Biosciences, Inc. | 19.55 Million USD | -2358.67% |
| Immunic, Inc. | 1.33 Million USD | -35945.127% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1653.938% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1415.322% |
| Veracyte, Inc. | 12.63 Million USD | -3707.142% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 25.435% |
| FibroGen, Inc. | 170.45 Million USD | -182.093% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -5195.034% |
| Allakos Inc. | 41.46 Million USD | -1059.633% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1094.075% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -4343.6% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -318338.411% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -29331.87% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -235709.741% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -11248.643% |
| Precigen, Inc. | 7.09 Million USD | -6675.285% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 71.344% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -6471.573% |
| Incyte Corporation | 38.28 Million USD | -1155.888% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -159800.104% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -1013.911% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -4217.131% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -17159.225% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -101.499% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1746.339% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -137677.077% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1688.78% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -966.807% |
| Agenus Inc. | 350.24 Million USD | -37.287% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -449743.298% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -33785.976% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -962.963% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -1013.859% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -896.998% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -293155.35% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 43.345% |
| UroGen Pharma Ltd. | 100.21 Million USD | -379.815% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -46701.921% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -163.116% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -3387542.666% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -157553.115% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -122563.15% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -6934.996% |
| Chimerix, Inc. | 2.14 Million USD | -22327.332% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -49318.499% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1252.379% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -278369.709% |
| Pluri Inc. | 29.61 Million USD | -1523.808% |
| Cue Biopharma, Inc. | 14.69 Million USD | -3172.147% |
| MeiraGTx Holdings plc | 89.26 Million USD | -438.674% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -2252087.354% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -9759.381% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -677.835% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -361.922% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -6851.598% |
| NLS Pharmaceutics AG | 1.63 Million USD | -29331.87% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1424.16% |
| Nutriband Inc. | 241.28 Thousand USD | -199183.834% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -8695.354% |
| Vor Biopharma Inc. | 35.66 Million USD | -1248.407% |
| Roivant Sciences Ltd. | 499.74 Million USD | 3.783% |
| ProKidney Corp. | 4.41 Million USD | -10796.034% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -39120.392% |
| Daré Bioscience, Inc. | 5.31 Million USD | -8941.536% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 72.363% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -85004.779% |
| Bicycle Therapeutics plc | 44.95 Million USD | -969.584% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1135.462% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -569.631% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -446.759% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2818.439% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -19518.229% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -71135.852% |
| MediciNova, Inc. | 215.92 Thousand USD | -222588.328% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -19172.224% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -38030.953% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -42042.156% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -158.001% |
| Biomea Fusion, Inc. | 10.29 Million USD | -4570.183% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -760.814% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -13293.928% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -5148.794% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -3177.5% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -3822.679% |
| bluebird bio, Inc. | 330.32 Million USD | -45.566% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -3744.89% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -29495.486% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 57.593% |
| BioAtla, Inc. | 2.46 Million USD | -19446.423% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -405.506% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -8570.069% |
| DBV Technologies S.A. | 14.38 Million USD | -3243.592% |
| Fortress Biotech, Inc. | 88.59 Million USD | -442.76% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -4780.654% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -2439.703% |
| aTyr Pharma, Inc. | 15.09 Million USD | -3085.439% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -2184.502% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -147174.827% |
| Galecto, Inc. | 249 Thousand USD | -193009.237% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -29368.323% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 67.928% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -353.351% |
| Entera Bio Ltd. | 390 Thousand USD | -123192.821% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -18.79% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -7645.522% |
| Xencor, Inc. | 83.43 Million USD | -476.314% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -28402.786% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -10332.675% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -39177.225% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -5013.165% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -293155.35% |
| Portage Biotech Inc. | 47 Thousand USD | -1022968.085% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -38030.953% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -19794.166% |
| OncoCyte Corporation | 2.86 Million USD | -16659.916% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -319281.75% |
| Purple Biotech Ltd. | 351 Thousand USD | -136892.023% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -15121.336% |
| Onconetix, Inc. | 9.88 Million USD | -4763.98% |
| MacroGenics, Inc. | 33.97 Million USD | -1315.448% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -23540.228% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -9092.162% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -3427.045% |
| Aditxt, Inc. | 18.21 Million USD | -2539.381% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1698.347% |
| Curis, Inc. | 2.79 Million USD | -17109.807% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -22406.599% |
| Adagene Inc. | 22.3 Million USD | -2055.578% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -2773.959% |
| BeiGene, Ltd. | 930.18 Million USD | 48.307% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -128.819% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -59380.555% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 21.298% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -632586.842% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -19118.305% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -486.272% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -133.514% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -10254.048% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 82.076% |
| ADMA Biologics, Inc. | 141.41 Million USD | -240.015% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -693.744% |
| Clene Inc. | 32.16 Million USD | -1395.109% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -18815.893% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -2450.48% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -21806.241% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -848.93% |
| Adicet Bio, Inc. | 20.92 Million USD | -2198.041% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -148.893% |
| Absci Corporation | 15.95 Million USD | -2913.361% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -3042.142% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -2269.497% |
| Surrozen, Inc. | 3.37 Million USD | -14130.305% |
| Generation Bio Co. | 97.89 Million USD | -391.186% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -146052.584% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1649.471% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1800.712% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1859.262% |
| Invivyd, Inc. | 2.16 Million USD | -22109.792% |
| Cingulate Inc. | 3.13 Million USD | -15237.379% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -799.342% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -13645724.169% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -95895.033% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -8574.761% |
| Jaguar Health, Inc. | 35.86 Million USD | -1240.887% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -763141.27% |
| 2seventy bio, Inc. | 256.67 Million USD | -87.336% |
| Clearside Biomedical, Inc. | 43 Million USD | -1018.211% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -79641.625% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -740.559% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -8467.869% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -99816.259% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1600.771% |
| Innoviva, Inc. | 449.07 Million USD | -7.074% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -2278.169% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -604.737% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -2696.081% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -286.094% |
| Evaxion Biotech A/S | 10.86 Million USD | -4323.7% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -476.625% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -541.919% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -7302.124% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1172685.366% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1681.556% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -103306.882% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -1653.042% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -4608.137% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -13418.189% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -30822.315% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -38062.063% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -3229.009% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -52973.068% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -829.558% |
| ImmunityBio, Inc. | 883.67 Million USD | 45.586% |
| Korro Bio, Inc. | 33.2 Million USD | -1348.014% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -577.471% |
| Kineta, Inc. | 1.31 Million USD | -36410.402% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -204975.255% |
| BioVie Inc. | 6.11 Million USD | -7767.891% |
| Codexis, Inc. | 22.36 Million USD | -2050.072% |
| Celularity Inc. | 65.41 Million USD | -635.041% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -125446.214% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -214274.498% |
| Kodiak Sciences Inc. | 181.63 Million USD | -164.734% |
| Cibus, Inc. | 24.62 Million USD | -1852.975% |
| Annexon, Inc. | 31.35 Million USD | -1433.542% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -20431.255% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 66.919% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -540.815% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -12219.805% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -2885.158% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -331.287% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -944.423% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1397.111% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -48716.447% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -4096.928% |
| Alkermes plc | 290.73 Million USD | -65.391% |
| Arcellx, Inc. | 97.62 Million USD | -392.54% |
| Moolec Science SA | 2.64 Million USD | -18077.296% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -22275.151% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -7516.696% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1713.608% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -15401.032% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -19918.401% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -27646.22% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -727.526% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1587.935% |
| Geron Corporation | 85.89 Million USD | -459.776% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -956.563% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 92.163% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -417102.006% |
| Notable Labs, Ltd. | 2.04 Million USD | -23367.155% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1321.348% |
| Structure Therapeutics Inc. | 5.45 Million USD | -8717.933% |
| IN8bio, Inc. | 4.89 Million USD | -9727.141% |
| 89bio, Inc. | 27.1 Million USD | -1673.801% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -120110.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -795.289% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -18988.607% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -35837.369% |
| Liquidia Corporation | 3.5 Million USD | -13626.577% |
| Mustang Bio, Inc. | 2.49 Million USD | -19149.079% |
| Immunovant, Inc. | 138 Thousand USD | -348336.232% |
| Vericel Corporation | 88.14 Million USD | -445.525% |
| Quantum-Si incorporated | 15.3 Million USD | -3042.142% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -5413.611% |
| XOMA Corporation | 124.45 Million USD | -286.374% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -175389.781% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -588590.01% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3521.889% |
| Vaxcyte, Inc. | 29.22 Million USD | -1545.367% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -4310.181% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -236767.98% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -2227.293% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -28989.05% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -38062.063% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -119215.633% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -46493.217% |
| PepGen Inc. | 20.1 Million USD | -2291.773% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -83670.383% |
| United Therapeutics Corporation | 700 Million USD | 31.308% |
| Solid Biosciences Inc. | 26.26 Million USD | -1730.733% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -48716.447% |
| Immuneering Corporation | 4.46 Million USD | -10674.063% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -475981.188% |
| Belite Bio, Inc | 886 Thousand USD | -54171.106% |
| Pharming Group N.V. | 171.54 Million USD | -180.301% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -100.67% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -2154.193% |
| uniQure N.V. | 138.4 Million USD | -247.407% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -2757.053% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -462.895% |
| Altimmune, Inc. | 671 Thousand USD | -71560.507% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3521.889% |
| Peak Bio, Inc. | 10.72 Million USD | -4384.71% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -5195.034% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -27423.869% |
| Benitec Biopharma Inc. | 284 Thousand USD | -169210.563% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -8.04% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -165911.953% |
| Compugen Ltd. | 1.35 Million USD | -35491.562% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -228340.441% |
| argenx SE | 20 Million USD | -2304.21% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -1024.356% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -468.674% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -2313.744% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -310.299% |
| PolyPid Ltd. | 11.77 Million USD | -3982.197% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -425.752% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -11400.646% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -82095.214% |
| Instil Bio, Inc. | 86.05 Million USD | -458.768% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1495.52% |
| Immunome, Inc. | 1.65 Million USD | -29041.939% |
| Verona Pharma plc | 51.32 Million USD | -836.784% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -4817.591% |
| Shattuck Labs, Inc. | 4.2 Million USD | -11343.17% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -132729.282% |
| Design Therapeutics, Inc. | 3.05 Million USD | -15665.311% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -183427.481% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -3279.547% |
| Achilles Therapeutics plc | 4.61 Million USD | -10319.112% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -28.663% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1497.535% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -12903.229% |
| Beam Therapeutics Inc. | 173.17 Million USD | -177.666% |
| Moolec Science SA | 2.64 Million USD | -18077.296% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -101129.895% |
| AEON Biopharma, Inc. | 278 Thousand USD | -172864.748% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -6745.7% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -143434.925% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -533.838% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -686.885% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1491.705% |
| Athira Pharma, Inc. | 1.58 Million USD | -30237.035% |
| HCW Biologics Inc. | 6.45 Million USD | -7352.861% |
| XOMA Corporation | 124.45 Million USD | -286.374% |
| NeurAxis, Inc. | 224.26 Thousand USD | -214312.735% |
| Lumos Pharma, Inc. | 6.58 Million USD | -7202.08% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -4817.591% |
| 180 Life Sciences Corp. | 1.32 Million USD | -36325.52% |
| Nektar Therapeutics | 230.4 Million USD | -108.698% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -2313.744% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -2715.214% |
| Arvinas, Inc. | 3.4 Million USD | -14042.412% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -30822.315% |
| Palisade Bio, Inc. | 369 Thousand USD | -130209.485% |
| Nutriband Inc. | 241.28 Thousand USD | -199183.834% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -29368.323% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -58113.317% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -115765.542% |
| Merus N.V. | 12.16 Million USD | -3853.642% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -274.406% |
| Neurogene Inc. | 16.25 Million USD | -2858.118% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -56.046% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1584.741% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -3380.831% |
| Rezolute, Inc. | 2.22 Million USD | -21481.777% |
| Clene Inc. | 32.16 Million USD | -1395.109% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -274583.667% |
| BeyondSpring Inc. | 3.99 Million USD | -11936.095% |
| Synlogic, Inc. | 17.27 Million USD | -2683.456% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -36887.846% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1373734.286% |
| Peak Bio, Inc. | 10.72 Million USD | -4384.71% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -826.067% |
| Krystal Biotech, Inc. | 8.09 Million USD | -5840.722% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -171.638% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -6713.689% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -351922.783% |
| MannKind Corporation | 382.37 Million USD | -25.75% |
| Ikena Oncology, Inc. | 10.73 Million USD | -4377.947% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -117465.281% |
| Gossamer Bio, Inc. | 212.46 Million USD | -126.317% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -276245.977% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -5148.794% |
| Legend Biotech Corporation | 328.67 Million USD | -46.298% |
| Mural Oncology plc | 15 Million USD | -3103.691% |
| Disc Medicine, Inc. | 2.1 Million USD | -22786.34% |
| Champions Oncology, Inc. | 7.43 Million USD | -6371.629% |
| REGENXBIO Inc. | 89.29 Million USD | -438.517% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -56158.768% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -86854.367% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -8781.455% |
| Vaxart, Inc. | 26.51 Million USD | -1713.54% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2971.029% |
| Cellectis S.A. | 92.85 Million USD | -417.853% |
| Longeveron Inc. | 2.04 Million USD | -23459.138% |
| Repare Therapeutics Inc. | 3.41 Million USD | -14000.938% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 65.576% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -932.027% |
| Revolution Medicines, Inc. | 87.94 Million USD | -446.759% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -277843.353% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -12063.977% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -151585.174% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -274666.857% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 40.519% |
| Denali Therapeutics Inc. | 52.24 Million USD | -820.43% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -3237.914% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -34895.779% |
| Cingulate Inc. | 3.13 Million USD | -15237.379% |
| Passage Bio, Inc. | 26.29 Million USD | -1728.714% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -7114.434% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -117753.431% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -53685.459% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -2238.612% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -19517.228% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -15296.798% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -59190.012% |
| OmniAb, Inc. | 25.56 Million USD | -1781.155% |
| Anew Medical, Inc. | 1.6 Million USD | -29859.003% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1525.407% |
| Lipocine Inc. | 17.16 Thousand USD | -2801030.141% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -4031.655% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1288.593% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -8040.125% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -741.03% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -236767.98% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -9209.622% |
| Ocugen, Inc. | 6.94 Million USD | -6827.561% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -3303.227% |
| Q32 Bio Inc. | 1.31 Million USD | -36382.701% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -71453.869% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1375.881% |
| Equillium, Inc. | 824 Thousand USD | -58254.612% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -5196.2% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -159751.2% |
| Dominari Holdings Inc. | 3.02 Million USD | -15779.855% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -508797.52% |
| vTv Therapeutics Inc. | 529 Thousand USD | -90796.408% |
| Bio-Techne Corporation | 419.53 Million USD | -14.612% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -567.873% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -148.412% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -2747.241% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -2012.477% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -7837.306% |
| Nkarta, Inc. | 88.33 Million USD | -444.315% |
| BioCardia, Inc. | 1.31 Million USD | -36465.932% |
| Iterum Therapeutics plc | 19.5 Million USD | -2364.719% |